Oxyphenbutazonum (Tanderil) as an adjuvant in treatment of dendritic keratitis. Double-blind trial using fluorescein-rose bengal vital staining.
D002986:Clinical Trials as Topic; D004396:Coloring Agents; D003315:Cornea; D004847:Epithelial Cells; D005260:Female; D005452:Fluoresceins; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D010919:Placebos; D012395:Rose Bengal
D004396:Coloring Agents; D005452:Fluoresceins; D010919:Placebos; D012395:Rose Bengal; D010113:Oxyphenbutazone; D007065:Idoxuridine